^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ovarian Cancer |
| Drug: | capecitabine (Thymidylate synthase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
…the NCCN Panel added a recommendation for recurrence therapy for mucinous carcinomas…2) capecitabine/oxaliplatin…
